Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
7.13
-0.10 (-1.38%)
At close: Aug 15, 2025, 3:07 PM

Abeona Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.59 -1.98 -0.61 -0.39
PEG Ratio
0.09 0.04 0.01 0.07
PS Ratio
n/a 30.60 17.13 11.16
PB Ratio
5.19 7.22 0.90 0.79
P/FCF Ratio
-3.91 -2.87 -0.56 -0.48
P/OCF Ratio
-4.08 -2.89 -0.56 -0.51
OCF/S Ratio
n/a -10.57 -30.75 -21.89
Debt / Equity Ratio
0.52 0.36 0.29 0.22
Quick Ratio
6.08 4.15 6.83 3.39
Current Ratio
6.08 4.15 6.83 3.39
Asset Turnover
n/a 0.05 0.02 0.04
Interest Coverage
-15.26 -112.76 -61.49 -24.48
Return on Equity
-1.45 -3.65 -1.48 -2
Return on Assets
-0.59 -0.85 -0.62 -1.07
Return on Invested Capital
-0.65 -0.91 -0.64 -1.39
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 0.54 0.68 -0.49
Net Profit Margin
n/a -15.48 -28.07 -28.31
Pretax Profit Margin
n/a -15.48 -30.75 -28.31
Operating Profit Margin
n/a -13.47 -32.01 -29.95
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -14.45 -24.32 -25.6